Literature DB >> 25190805

An electrostatic interaction at the tetrahelix bundle promotes phosphorylation-dependent cystic fibrosis transmembrane conductance regulator (CFTR) channel opening.

Wei Wang1, Bryan C Roessler2, Kevin L Kirk3.   

Abstract

The CFTR channel is an essential mediator of electrolyte transport across epithelial tissues. CFTR opening is promoted by ATP binding and dimerization of its two nucleotide binding domains (NBDs). Phosphorylation of its R domain (e.g. by PKA) is also required for channel activity. The CFTR structure is unsolved but homology models of the CFTR closed and open states have been produced based on the crystal structures of evolutionarily related ABC transporters. These models predict the formation of a tetrahelix bundle of intracellular loops (ICLs) during channel opening. Here we provide evidence that residues E267 in ICL2 and K1060 in ICL4 electrostatically interact at the interface of this predicted bundle to promote CFTR opening. Mutations or a thiol modifier that introduced like charges at these two positions substantially inhibited ATP-dependent channel opening. ATP-dependent activity was rescued by introducing a second site gain of function (GOF) mutation that was previously shown to promote ATP-dependent and ATP-independent opening (K978C). Conversely, the ATP-independent activity of the K978C GOF mutant was inhibited by charge- reversal mutations at positions 267 or 1060 either in the presence or absence of NBD2. The latter result indicates that this electrostatic interaction also promotes unliganded channel opening in the absence of ATP binding and NBD dimerization. Charge-reversal mutations at either position markedly reduced the PKA sensitivity of channel activation implying strong allosteric coupling between bundle formation and R domain phosphorylation. These findings support important roles of the tetrahelix bundle and the E267-K1060 electrostatic interaction in phosphorylation-dependent CFTR gating.
© 2014 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  ABC Transporter; Allosteric Regulation; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator (CFTR); Ion Channel; Phosphorylation

Mesh:

Substances:

Year:  2014        PMID: 25190805      PMCID: PMC4215221          DOI: 10.1074/jbc.M114.595710

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  47 in total

1.  Electrostatics of nanosystems: application to microtubules and the ribosome.

Authors:  N A Baker; D Sept; S Joseph; M J Holst; J A McCammon
Journal:  Proc Natl Acad Sci U S A       Date:  2001-08-21       Impact factor: 11.205

2.  Thiazolidinone CFTR inhibitor identified by high-throughput screening blocks cholera toxin-induced intestinal fluid secretion.

Authors:  Tonghui Ma; Jay R Thiagarajah; Hong Yang; Nitin D Sonawane; Chiara Folli; Luis J V Galietta; A S Verkman
Journal:  J Clin Invest       Date:  2002-12       Impact factor: 14.808

3.  Phosphorylation of the R domain by cAMP-dependent protein kinase regulates the CFTR chloride channel.

Authors:  S H Cheng; D P Rich; J Marshall; R J Gregory; M J Welsh; A E Smith
Journal:  Cell       Date:  1991-09-06       Impact factor: 41.582

4.  The First Nucleotide Binding Domain of Cystic Fibrosis Transmembrane Conductance Regulator Is a Site of Stable Nucleotide Interaction, whereas the Second Is a Site of Rapid Turnover.

Authors:  Luba Aleksandrov; Andrei A Aleksandrov; Xiu-Bao Chang; John R Riordan
Journal:  J Biol Chem       Date:  2002-02-22       Impact factor: 5.157

5.  Activating cystic fibrosis transmembrane conductance regulator channels with pore blocker analogs.

Authors:  Wei Wang; Ge Li; John Paul Clancy; Kevin L Kirk
Journal:  J Biol Chem       Date:  2005-04-27       Impact factor: 5.157

6.  Cystic fibrosis transmembrane conductance regulator: a molecular model defines the architecture of the anion conduction path and locates a "bottleneck" in the pore.

Authors:  Yohei Norimatsu; Anthony Ivetac; Christopher Alexander; John Kirkham; Nicolette O'Donnell; David C Dawson; Mark S P Sansom
Journal:  Biochemistry       Date:  2012-03-07       Impact factor: 3.162

7.  Optimization of the additive CHARMM all-atom protein force field targeting improved sampling of the backbone φ, ψ and side-chain χ(1) and χ(2) dihedral angles.

Authors:  Robert B Best; Xiao Zhu; Jihyun Shim; Pedro E M Lopes; Jeetain Mittal; Michael Feig; Alexander D Mackerell
Journal:  J Chem Theory Comput       Date:  2012-07-18       Impact factor: 6.006

8.  Regulation of the gating of cystic fibrosis transmembrane conductance regulator C1 channels by phosphorylation and ATP hydrolysis.

Authors:  T C Hwang; G Nagel; A C Nairn; D C Gadsby
Journal:  Proc Natl Acad Sci U S A       Date:  1994-05-24       Impact factor: 11.205

9.  Phenylalanine-508 mediates a cytoplasmic-membrane domain contact in the CFTR 3D structure crucial to assembly and channel function.

Authors:  Adrian W R Serohijos; Tamás Hegedus; Andrei A Aleksandrov; Lihua He; Liying Cui; Nikolay V Dokholyan; John R Riordan
Journal:  Proc Natl Acad Sci U S A       Date:  2008-02-27       Impact factor: 11.205

10.  The two ATP binding sites of cystic fibrosis transmembrane conductance regulator (CFTR) play distinct roles in gating kinetics and energetics.

Authors:  Zhen Zhou; Xiaohui Wang; Hao-Yang Liu; Xiaoqin Zou; Min Li; Tzyh-Chang Hwang
Journal:  J Gen Physiol       Date:  2006-09-11       Impact factor: 4.086

View more
  16 in total

1.  Positioning of extracellular loop 1 affects pore gating of the cystic fibrosis transmembrane conductance regulator.

Authors:  Daniel T Infield; Guiying Cui; Christopher Kuang; Nael A McCarty
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2015-12-18       Impact factor: 5.464

2.  Functional Architecture of the Cytoplasmic Entrance to the Cystic Fibrosis Transmembrane Conductance Regulator Chloride Channel Pore.

Authors:  Yassine El Hiani; Paul Linsdell
Journal:  J Biol Chem       Date:  2015-05-05       Impact factor: 5.157

3.  Channel Gating Regulation by the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) First Cytosolic Loop.

Authors:  Annette Ehrhardt; W Joon Chung; Louise C Pyle; Wei Wang; Krzysztof Nowotarski; Cory M Mulvihill; Mohabir Ramjeesingh; Jeong Hong; Sadanandan E Velu; Hal A Lewis; Shane Atwell; Steve Aller; Christine E Bear; Gergely L Lukacs; Kevin L Kirk; Eric J Sorscher
Journal:  J Biol Chem       Date:  2015-12-01       Impact factor: 5.157

4.  Murine and human CFTR exhibit different sensitivities to CFTR potentiators.

Authors:  Guiying Cui; Nael A McCarty
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2015-07-24       Impact factor: 5.464

Review 5.  Current insights into the role of PKA phosphorylation in CFTR channel activity and the pharmacological rescue of cystic fibrosis disease-causing mutants.

Authors:  Stephanie Chin; Maurita Hung; Christine E Bear
Journal:  Cell Mol Life Sci       Date:  2016-10-08       Impact factor: 9.261

Review 6.  Molecular modelling and molecular dynamics of CFTR.

Authors:  Isabelle Callebaut; Brice Hoffmann; Pierre Lehn; Jean-Paul Mornon
Journal:  Cell Mol Life Sci       Date:  2016-10-07       Impact factor: 9.261

7.  Analysis of cystic fibrosis-associated P67L CFTR illustrates barriers to personalized therapeutics for orphan diseases.

Authors:  Carleen M Sabusap; Wei Wang; Carmel M McNicholas; W Joon Chung; Lianwu Fu; Hui Wen; Marina Mazur; Kevin L Kirk; James F Collawn; Jeong S Hong; Eric J Sorscher
Journal:  JCI Insight       Date:  2016-09-08

8.  G551D mutation impairs PKA-dependent activation of CFTR channel that can be restored by novel GOF mutations.

Authors:  Wei Wang; Lianwu Fu; Zhiyong Liu; Hui Wen; Andras Rab; Jeong S Hong; Kevin L Kirk; Steven M Rowe
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2020-09-02       Impact factor: 5.464

9.  Slowing ribosome velocity restores folding and function of mutant CFTR.

Authors:  Kathryn E Oliver; Robert Rauscher; Marjolein Mijnders; Wei Wang; Matthew J Wolpert; Jessica Maya; Carleen M Sabusap; Robert A Kesterson; Kevin L Kirk; Andras Rab; Ineke Braakman; Jeong S Hong; John L Hartman; Zoya Ignatova; Eric J Sorscher
Journal:  J Clin Invest       Date:  2019-12-02       Impact factor: 14.808

10.  Identification of binding sites for ivacaftor on the cystic fibrosis transmembrane conductance regulator.

Authors:  Onofrio Laselva; Zafar Qureshi; Zhi-Wei Zeng; Evgeniy V Petrotchenko; Mohabir Ramjeesingh; C Michael Hamilton; Ling-Jun Huan; Christoph H Borchers; Régis Pomès; Robert Young; Christine E Bear
Journal:  iScience       Date:  2021-05-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.